NABEN

Welcome to the Brand page for “NABEN”, which is offered here for Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; chemical preparations for pharmaceutical or medical purposes, for treating neuropsychiatric disorders, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; chemical reagents for medical or veterinary purposes; sodium salts for medical purposes;.

Its status is currently believed to be active. Its class is unavailable. “NABEN” is believed to be currently owned by “SyneuRx International (Taiwan) Corp.”